Ron Baron started to build up the position in BridgeBio Pharma in Q4 2020 and continued to invest until Q1 2021. Since then they sold 1.01 Million shares. The investor completely sold their stake between Q2 2021 and Q4 2021.
Avg closing price
Price range
Sold -487 Thousand shares
Q4 2021
Avg closing price
$42.31
Price range
$11.38
-
$53.41
Sold 29.6% shares (-205 Thousand shares)
Q3 2021
Avg closing price
$53.60
Price range
$46.87
-
$64.24
Sold 31.7% shares (-322 Thousand shares)
Q2 2021
Avg closing price
$57.11
Price range
$46.47
-
$63.93
Increased shares by 3817.6% (+988 Thousand shares)
Q1 2021